Proceeding contribution from Angela Watkinson (Conservative) in the House of Commons on Thursday, 15 June 2006. It occurred during Debate on bill on Commissioner for Older People (Wales) Bill (HL).
Commissioner for Older People (Wales) Bill [Lords]
What relationship does my hon. Friend predict that the new commissioner will have with the National Institute for Health and Clinical Excellence, which recently decided not to approve quality of life improving drugs for people suffering from the early stages of Alzheimer’s disease? Increasing numbers of people are in need of those drugs, which also benefit their carers. People often suffer for many years because although their general health is good, those particular drugs have not been approved by NICE. Does my hon. Friend foresee that the commissioner will continue the campaign to try to get them approved?
Secondary information
- Type
- Proceeding contribution
- Reference
- 447 c933
- Session
- 2005-06
- Chamber / Committee
- House of Commons chamber
- Subjects
- Complaints Access Devolved matters Age Cross border cooperation Equality Finance Functions Pensioners Powers of entry Protection Powers Public appointments Poverty Pensions Public bodies Older people National Assembly for Wales Staff Wales Research Commissioner for Older People in Wales
- Legislation
- Commissioner for Older People (Wales) Bill (HL) 2005-06
- Link
- View this Proceeding contribution on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2024-04-22 00:00:36 +0100
- URI
- http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_330630
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_330630
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_330630